CSS
VKTX icon

Cubist Systematic Strategies’s Viking Therapeutics VKTX Stock Holding History

Cubist Systematic Strategies’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.69M Sell
64,355
-532,295
-89% -$15.9M 0.01% 1663
2025
Q2 		$15.8M Buy
+596,650
New +$15.7M 0.07% 378
2024
Q1 		– Sell
-79,459
Closed -$3.54M – 4316
2023
Q4 		$1.48M Buy
+79,459
New +$1.04M 0.01% 1754
2023
Q3 		– Sell
-222,587
Closed -$3.18M – 3958
2023
Q2 		$3.61M Buy
222,587
+9,341
+4% +$196K 0.02% 1051
2023
Q1 		$3.55M Sell
213,246
-134,271
-39% -$1.39M 0.02% 1210
2022
Q4 		$3.27M Buy
347,517
+57,245
+20% +$256K 0.02% 1408
2022
Q3 		$790K Sell
290,272
-41,264
-12% -$135K ﹤0.01% 2815
2022
Q2 		$958K Buy
331,536
+49,230
+17% +$122K 0.01% 2517
2022
Q1 		$847K Buy
282,306
+239,182
+555% +$858K 0.01% 2169
2021
Q4 		$198K Buy
+43,124
New +$242K ﹤0.01% 3033
2021
Q3 		– Sell
-21,810
Closed -$131K – 3193
2021
Q2 		$131K Sell
21,810
-7,359
-25% -$43.7K ﹤0.01% 2679
2021
Q1 		$184K Buy
29,169
+4,704
+19% +$33.1K ﹤0.01% 2501
2020
Q4 		$138K Sell
24,465
-1,782
-7% -$10.8K ﹤0.01% 2354
2020
Q3 		$153K Sell
26,247
-1,202
-4% -$8.28K ﹤0.01% 2199
2020
Q2 		$198K Buy
+27,449
New +$182K ﹤0.01% 2040
2019
Q3 		– Sell
-129,196
Closed -$1.07M – 2507
2019
Q2 		$1.07M Buy
+129,196
New +$1.1M 0.02% 1004
2019
Q1 		– Sell
-89,783
Closed -$687K – 2432
2018
Q4 		$687K Buy
+89,783
New +$1.07M 0.03% 763
2018
Q3 		– Sell
-13,600
Closed -$129K – 2093
2018
Q2 		$129K Buy
+13,600
New +$90.5K 0.01% 1470

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cubist Systematic Strategies's VKTX Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Viking Therapeutics (VKTX) stake by 89% in Q3 2025, selling an estimated $15.9M and leaving 64,355 shares worth $1.69M. The position accounts for 0.01% of the portfolio, ranked #1663.

Cubist Systematic Strategies first reported a position in VKTX in Q2 2018 and has held it in 18 quarters since. The position peaked at $15.8M in Q2 2025. 370 funds tracked by Wall St. Rank hold VKTX as of Q3 2025.

  • Cubist Systematic Strategies held 64,355 shares of Viking Therapeutics worth $1.69M as of Q3 2025.
  • Cubist Systematic Strategies sold 532,295 Viking Therapeutics shares in Q3 2025, an estimated $15.9M.
  • Viking Therapeutics made up 0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1663 holding.
  • Cubist Systematic Strategies first reported a position in Viking Therapeutics in Q2 2018 and has held it in 18 quarters since.
  • Cubist Systematic Strategies's Viking Therapeutics position peaked at $15.8M in Q2 2025.
  • 370 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.